Medications for Pediatric Ulcerative Colitis
3 results
Inflectra (infliximab-dyyb)
(infliximab-dyyb)Pfizer Laboratories Div Pfizer Inc
Usage: INFLECTRA is indicated for treating moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults and pediatric patients (6+). It aims to reduce symptoms, maintain remission, and improve physical function while monitoring for safety.
Remicade (infliximab)
(INFLIXIMAB)Janssen Biotech, Inc.
Usage: REMICADE is indicated for treating moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults and pediatric patients (6+ years). It helps reduce symptoms, maintain remission, and improve physical function for patients unresponsive to conventional therapies.
Renflexis (infliximab)
(infliximab)Merck Sharp & Dohme LLC
Usage: RENFLEXIS is indicated for adults and pediatric patients with moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis, particularly for those who have not responded adequately to conventional therapies. It aids in reducing symptoms and achieving clinical remission.